Publications

Kerr J, Britton P, Macartney K. Influenza associated myositis: a single-centre, 5-year retrospective study. European Journal of Pediatrics. 2021;180:577–584 . [Abstract]

Deng L, Barton B, Lorenzo J, Rashid H, Dastouri F, Booy R. Longer term outcomes following meningococcal B invasive meningococcal disease. Journal of Paediatrics and Child Health. . [Full text]

Patel C, Dalton L, Dey A, Macartney K, Beard F . Impact of the COVID-19 pandemic on pharmacist-administered vaccination services [Letter]. Research in Social and Administrative Pharmacy. 2021;17:2040–2041 doi: 10.1016/j.sapharm.2020.08.021 . [Full text]

Li-Kim-Moy JP, Macartney K. Time to prioritise influenza vaccination in pregnancy. The Lancet Infectious Diseases. 2021;21:P8-10. [Abstract]

Kerr EJ, Malo J, Vette K, Nimmo GR, Lambert SB. Evidence for an increase in the intensity of inter‐seasonal influenza, Queensland, Australia, 2009‐2019. Influenza and other respiratory viruses. . [Full text]

Lu X, Quinn H, Menzies R, Hueston L, Gilbert L, McIntyre PB. Diphtheria immunity in Australia: should we be concerned? . Infectious Disorders - Drug Targets. 2020;20(3):323-329. doi: 10.2174/1871526518666181011114834. [Abstract]

Lu X, Quinn H, Menzies R, Hueston L, Gilbert L, McIntyre PB. Hepatitis B seroepidemiology in Australia one decade after universal vaccination of infants and adolescents. Infectious Disorders - Drug Targets. 2020;20(3):341-347. doi: 10.2174/1871526518666181001144303. [Epub - Abstract]

Lu X, Quinn H, Menzies R, Hueston L, Gilbert L, McIntyre PB. Tetanus immunity and epidemiology in Australia, 1993-2010 . Infectious Disorders - Drug Targets. 2020;20(3):330-340. doi: 10.2174/1871526518666181005111405 . [Abstract]

Atwell K, Cunneen R, Beard B, Hendry A, Lawrence D. Financial interventions to increase vaccine coverage. Pediatrics. 2020;146:e20200724. doi: 10.1542/peds.2020-0724. [Full text]

Chacon GP, Estcourt MJ, Totterdell J, Campbell DE, Perrett KP, Marsh JA, Richmond PC, Wood N, Gold MS, Holt PG, Waddington CS, Snelling TL. OPTIMUM study protocol: an adaptive randomised controlled trial of a mixed whole-cell/ acellular pertussis vaccine schedule. BMJ Open. 2020;10:e042838. doi:10.1136/ bmjopen-2020-042838. [Abstract]